AMS Health Sciences, Inc. Receives Non-Compliance Notification from AMEX

AMS Health Sciences, Inc. (AMEX:AMM), announced
today that on January 12, 2006 the American Stock Exchange (the
"AMEX") notified the Company that the Company is not in compliance
with AMEX's continued listing standards as set forth in Part 10 of the
AMEX Company Guide. Specifically, the Company is not in compliance
with Section 1003(a)(ii) of the Company Guide, which provides that
AMEX will consider suspending or delisting securities of a company
that has shareholder's equity of less than $4,000,000 and has losses
from continuing operations and/or net losses in three out of its four
most recent fiscal years. The Company's shareholder's equity as
reported on its Form 10-Q for the quarter ended September 30, 2005 was
$3,737,460 and the Company has recorded net losses for the 2004, 2003
and 2002 fiscal years.
   In order to maintain its AMEX listing, the Company must submit a
plan by February 12, 2006 advising the AMEX of action the Company has
taken or will take that would bring it in compliance with Section
1003(a)(ii) of the AMEX Company Guide within a maximum of 18 months
from the date the Company received the non-compliance letter. The
Company plans to make a timely submission to the AMEX staff in which
it will outline the timeframe within which the Company intends to cure
the listing deficiency and to regain its compliance with the AMEX
continued listing requirements. If the Company's plan is accepted, the
Company may be able to continue its listing during the plan period,
which can be as long as 18 months, during which time the Company will
be subject to periodic review by the AMEX to determine whether the
Company is making progress consistent with its plan.

   AMS Health Sciences, Inc. sells more than 60 natural nutritional
supplements, weight management products, and natural skincare products
through independent distributors across the U.S. and Canada. More
information about the Company is available at
http://www.amsonline.com.